ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,458Medicare Part D Prescriptions Filled, Including Refills

Rank: 110 out of 1269

$447K Total Retail Price of All Prescriptions

Rank: 189 out of 1269

616 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 616 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

5% of this provider’s 616 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 7,016 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
SIMVASTATIN 375 333 1 3
LISINOPRIL 342 297 2 1
ATENOLOL 327 300 3 14
AMLODIPINE BESYLATE 260 229 4 2
HYDROCHLOROTHIAZIDE 258 236 5 10
METOPROLOL TARTRATE 246 197 6 6
WARFARIN SODIUM 213 196 7 12
ATORVASTATIN CALCIUM 209 185 8 7
METFORMIN HCL 191 163 9 9
LEVOTHYROXINE SODIUM 189 157 10 4
OMEPRAZOLE 179 134 11 8
FUROSEMIDE 155 135 12 5
PRAVASTATIN SODIUM 122 107 13 11
METOPROLOL SUCCINATE 107 100 14 13
CLOPIDOGREL 107 90 14 32
TRAMADOL HCL 105 103 16 16
LOSARTAN POTASSIUM 103 95 17 15
MELOXICAM 98 87 18 68
ZOLPIDEM TARTRATE 97 64 19 19
ISOSORBIDE MONONITRATE ER 97 79 19 63
TAMSULOSIN HCL 96 84 21 31
GLYBURIDE 96 79 R 21 94
PLAVIX 93 82 23 47
AZITHROMYCIN 92 68 24 42
SERTRALINE HCL 90 61 25 23
PROAIR HFA 88 60 26 61
CITALOPRAM HBR 80 73 27 21
PANTOPRAZOLE SODIUM 72 61 28 18
GABAPENTIN 65 30 29 17
PAROXETINE HCL 64 53 30 71
HYDROCODONE-ACETAMINOPHEN 62 58 S3 31 20
KLOR-CON M20 61 57 32 60
DIOVAN 60 57 33 35
CARVEDILOL 57 53 34 29
OXYCODONE HCL 56 51 S2 35 34
RANITIDINE HCL 55 37 36 27
VERAPAMIL ER 55 53 36 134
ENALAPRIL MALEATE 54 43 38 79
DONEPEZIL HCL 53 53 39 22
ADVAIR DISKUS 51 45 40 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.